Ear Emergencies

Published on 10/02/2015 by admin

Filed under Emergency Medicine

Last modified 22/04/2025

Print this page

rate 1 star rate 2 star rate 3 star rate 4 star rate 5 star
Your rating: none, Average: 0 (0 votes)

This article have been viewed 2701 times

27 Ear Emergencies

Ear Pain

Ear pain may be referred from or occur as a result of infections, trauma, or a foreign body affecting the ear.

Infections

Ear pain is commonly caused by infection. Any portion of the ear can become infected. The disease state is categorized by the portion of the ear that is primarily affected.

Treatment

Treatment consists of débridement or aural toilet and antibiotics. Despite a relative lack of controlled studies, the American Academy of Otolaryngology–Head and Neck Surgery Foundation has released clinical practice guidelines based on evidence available as of 2005 (Fig. 27.1; also see the Patient Teaching Tips box).2 Briefly, these guidelines are as follows:

1. Distinguish acute external otitis from other causes of otalgia, otorrhea, and inflammation. Diagnostic criteria include rapid onset (2 to 3 days) and a duration of less than 3 weeks. Symptoms include otalgia, itching, or fullness. Signs include tenderness of the pinna or tragus or visual evidence of canal erythema, edema, or otorrhea.

2. Assess for factors that may complicate the disease or treatment (e.g., perforation of the tympanic membrane or eustachian tubes, immunocompromising states, previous radiotherapy). These factors raise the level of treatment needed and heighten suspicion for more invasive disease states such as necrotizing otitis externa (see later). These guidelines pertain to patients older than 2 years with normal states of health.

3. Pay attention to assessment and treatment of pain! Mild to moderate pain usually responds to acetaminophen or a nonsteroidal antiinflammatory drug alone or in combination with an opioid.

4. Topical preparations are first-line agents for the treatment of acute uncomplicated otitis externa. Reserve systemic therapy for immunocompromised patients or extension of disease beyond the ear canal. Topical therapy produces drug concentrations 100 to 1000 times that available with systemic administration and can thus overwhelm resistance mechanisms. No clear evidence points to the superiority of one particular treatment. Antiseptic and acidifying agents (e.g., aluminum acetate and boric acid) appear to work as well as antibiotic-containing solutions (e.g., solutions that contain cortisone and Neosporin or a fluoroquinolone). Corticosteroids in the drops decrease the duration of pain by approximately 1 day.3

5. Make sure that the patient can instill the drops correctly. Edema can prevent the drops from entering the canal. Debris or detritus should be removed or irrigated out. Placement of a compressed cellulose or ribbon gauze wick in the canal will enable the drops to penetrate, but placement can be painful. Within 1 to 2 days the canal edema should subside, and the wick falls out or can be removed (Fig. 27.2).

6. If you cannot be sure that the tympanic membrane is intact, use a nonototoxic, pH-balanced preparation such as ofloxacin and ciprofloxacin-dexamethasone.

7. Educate and reassess your patients. Pain should decrease significantly in 1 to 2 days and resolve by 4 to 7 days. Failure to improve may indicate more invasive disease (e.g., necrotizing otitis), inability of drops to reach the canal (wick needed), or noncompliance with therapy.

image

Fig. 27.1 Algorithm for the treatment of acute otitis externa.

TM, Tympanic membrane.

(Adapted from Rosenfeld RM, Brown L, Cannon CR, et al. Clinical practice guideline: acute otitis externa. Otolaryngol Head Neck Surg 2006;134;S4-23.)

Otitis Media (Acute and Chronic)

Accumulation of fluid in the middle ear (medial to the tympanic membrane) is termed otitis media. Fluid collections can be clinically sterile, as in barotrauma-mediated effusions or chronic otitis media with effusion, or can result from infectious causes (acute otitis media [AOM]). Infection-mediated effusions may be serous (usually viral in origin) or suppurative (primary or secondary bacterial infection). The common link between all these processes is eustachian tube dysfunction. The eustachian tube acts as a vent and conduit between the middle ear and posterior pharynx in which air pressure between the middle ear and ambient air is equalized and fluid can drain from the middle ear cavity. After infections (primarily upper respiratory infections [URIs]), edema can cause blockage of the tube. Air is easily absorbed through the middle ear tissues, thereby leading to a relative negative pressure in the middle ear. This negative pressure draws fluid into the enclosed cavity. Native or invasive bacteria can work their way into this enclosed area and proliferate.4,5 Common bacterial pathogens are the same as those frequently found in sinus infections and include Streptococcus pneumoniae, nontypeable Haemophilus influenzae, and Moraxella catarrhalis. Currently, approximately 60% to 70% of S. pneumoniae species are covered by the polyvalent pneumococcal vaccine (Pneumovax).6,7

Barotrauma refers to the rapid development of relative differences in pressure between the middle ear and the outside environment. Rapid rises in middle ear pressure (relative to the outside, such as in ascent while flying or diving) usually forces air out of the eustachian tube and equalizes pressure. A relative drop in middle ear pressure (during descent) that is not equalized (as a result of collapsed or obstructed eustachian tubes) generates a vacuum force that draws fluid from tissues into the middle ear space. The resultant effusion may remain sterile or become secondarily infected. Very rapid changes in pressure can even cause direct trauma to the tympanic membrane, including rupture or hemorrhage within the layers of the membrane itself.

Acute otitis media is primarily a disease of children. In early childhood the eustachian tubes are not angled downward and do not drain well spontaneously. The relatively small tube size and higher frequency of URIs in children 6 to 24 months old lead to the highest incidence of otitis media in this age group. Another increase in the incidence of otitis media occurs at 5 to 6 years, which coincides with entrance into school and a higher frequency of URIs. The craniofacial abnormalities seen with some developmental disorders (e.g., Down syndrome) also predispose to the development of middle ear effusions.

Otitis media is one of the most common reasons for pediatric physician visits, with estimates that $5 billion is spent as direct or indirect costs annually. A significant proportion of cases are probably misdiagnosed, and guidelines have been issued to ensure proper diagnosis and thus curb wasting of resources.8 “Visualization of the tympanic membrane with identification of a middle ear effusion and inflammatory changes is necessary to establish the diagnosis with certainty.”8 Effusions are signified on physical examination by bulging of the tympanic membrane, bubbles or fluid levels behind the membrane, loss of the light reflex (opacification or cloudiness of the membrane), and (most definitively) loss of tympanic membrane mobility on pneumatic insufflation. Newer modalities, such as acoustic reflectometry and tympanometry, also demonstrate middle ear effusions but are not available in many EDs. Tympanic membrane injection (common in crying children) or the presence of fluid alone is not enough to make the diagnosis of AOM. Accompanying fever, pain, purulent drainage, or other systemic signs point to acute infection.

Chronic otitis media is defined as (1) the chronic presence of middle ear effusion in the absence of acute signs of infection or (2) chronic complications from otitis media, including persistent perforation of the tympanic membrane.

The role of infectious organisms in chronic otitis media is unclear. It was originally thought to be a noninfectious entity, but studies have shown the presence of bacteria (and bacterial DNA, mRNA, and proteins) in a biofilm model of chronic otitis media.9 Current guidelines offer the option of a trial of antibiotics (typically amoxicillin) or watchful waiting as treatment.8

Treatment

American physicians have historically treated otitis media with antibiotics, whereas European physicians are typically less likely to do so. A 2005 study compared immediate antibiotic treatment with watchful waiting for nonsevere otitis media.10 In the watchful waiting group, 66% of children had complete resolution of symptoms with no antibiotic treatment, no adverse outcomes, cost savings, and similar patient satisfaction.

Treatment options and recommendations by the American Academy of Pediatrics for acute otitis media include the following8:

1. Pain management must be addressed in patients with AOM. Particular attention should be paid to pain management in the first 24 hours of any treatment regimen.

2. Observation without the use of antibacterial agents is an option for the first 2 to 3 days in selected children11 (Table 27.1). The child must be otherwise healthy and in a sound social environment with an adult capable of watching the child closely and returning to the physician if the condition deteriorates.

3. If antimicrobial treatment is chosen, the first-line agent should be amoxicillin, 80 to 90 mg/kg/day. With treatment failures or cases in which broader β-lactamase coverage is desired, amoxicillin, 90 mg/kg, with clavulanate, 6.4 mg/kg, in two divided doses can be used. Penicillin-allergic patients (non–type 1) can be treated with a third-generation cephalosporin (cefdinir, cefpodoxime, cefuroxime, or ceftriaxone). For patients with severe type 1 penicillin allergy, alternative treatments include azithromycin, clarithromycin, erythromycin-sulfisoxazole, and sulfamethoxazole-trimethoprim. Treatment is aimed at common pathogens, including S. pneumoniae, nontypeable H. influenzae, and M. catarrhalis. Mycoplasma species can also cause otitis media and are often responsible for blister formation on the tympanic membrane (bullous myringitis). Multiple virus species can cause otitis media and are obviously unaffected by antibiotics.

4. Failure of response in 2 to 3 days should prompt initiation of or a change in antibiotic treatment. If amoxicillin fails, alternatives include amoxicillin-clavulanate, cephalosporin (ceftriaxone), macrolides, and sulfa preparations.

Table 27.1 Acute Otitis Media Treatment Guidelines

AGE CERTAIN DIAGNOSIS OF ACUTE OTITIS MEDIA UNCERTAIN DIAGNOSIS
<6 mo Antibacterial therapy Antibacterial therapy
6 mo to 2 yr Antibacterial therapy Severe illness: antibacterial therapy
Nonsevere illness: observation option*
≥2 yr Severe illness: antibacterial therapy
Nonsevere illness: observation option*
Observation option*

* Observation: defer antibiotic treatment for 48 to 72 hours.

From Johnson NC, Holger JS. Pediatric acute otitis media: the case for delayed antibiotic treatment. J Emerg Med 2007;32:279-84.

Some authorities have suggested a compromise between meeting patients’ expectations and decreasing the inappropriate overuse of antibiotics.12,13 Patients can be given a “rescue” prescription, which they should have filled only if no improvement occurs in 2 to 3 days.

Chronic otitis media is not typically an emergency. The American Academies of Family Physicians, Pediatrics, and Otolaryngology–Head and Neck Surgeons have recently issued guidelines to direct the diagnosis and treatment of otitis media with effusion; they are summarized as follows:

Middle ear effusions in adults should be able to be explained clinically (e.g., after URI) and should resolve within a few weeks. Any other circumstances require otolaryngologic referral to evaluate for other nasopharyngeal disease, such as an obstructing tumor.

Necrotizing (Malignant) Otitis Externa

Necrotizing otitis externa (formerly known as malignant otitis externa) is aggressive extension of infection from the auditory canal to the skull base and other nearby bony structures. This complication occurs nearly exclusively in immunocompromised hosts, with elderly diabetic patients accounting for most of the affected population. It can be the initial complaint in patients with undiagnosed diabetes, and all patients with progressive ear infection need prompt evaluation for diabetes. The emergence of widespread human immunodeficiency virus infection now puts children at risk for a condition that was once almost exclusively an adult disease.14

Necrotizing otitis externa may be difficult to distinguish from simple otitis externa in the early stages, but exquisite otalgia and otorrhea unresponsive to topical measures point to the former diagnosis. The pain often extends to the temporomandibular joint and gets worse with chewing. Granulation tissue is frequently seen at the inferior portion of the canal where the cartilage and bone meet, at the site of the fissures of Santorini. Inflammation of bony structures as a result of the osteomyelitis can cause nerve palsies (facial nerve most frequently involved). Progression of the infection inward can lead to catastrophic complications such as brain or epidural abscess, sinus thrombophlebitis, and meningitis. Evaluation with computed tomography (CT) or magnetic resonance imaging (MRI) can show the extent of the invasive process and may be helpful in evaluating for intracranial complications, but arranging for such an evaluation should not delay initiation of treatment.

More than 95% of cases of necrotizing otitis externa are caused by P. aeruginosa, and antibiotic therapy should be aimed at this organism. Since the introduction of semisynthetic penicillins, antipseudomonal cephalosporins, and antipseudomonal fluoroquinolones, mortality from this disorder has decreased from 50% to 10%. Empiric treatment with ciprofloxacin, 400 mg intravenously every 8 hours, is reasonable. Alternative treatments are an antipseudomonal penicillin (e.g., ticarcillin-clavulanate [Timentin], 3.1 g intravenously every 6 hours) and cephalosporins (e.g., ceftazidime, 1 to 2 g every 8 hours). Recently, resistance of P. aeruginosa to ciprofloxacin has been reported to be as high as 33%. Resistance is related to widespread use of quinolones for the treatment of URIs, topical preparations for otitis media and externa, and inadequate treatment courses in patients with malignant otitis externa.15

Ramsay Hunt Syndrome

The combination of ear pain, ipsilateral facial paralysis, and vesicular lesions characterize Ramsay Hunt syndrome, also known as herpes zoster oticus. This reactivation of latent varicella-zoster infection in the geniculate ganglion with spread to the eighth cranial nerve (and frequently cranial nerves V, IX, and X) results in both auditory and vestibular dysfunction.16

Physical examination usually demonstrates vesicular lesions in the ear canal, but the variable course and innervation of the nervous structures may lead to involvement of the anterior aspect of the tongue, soft palate, pinna, and face. Because of the proximity of the ear to the eye, evaluation for ocular involvement is necessary. The disease tends to be self-limited and mortality is extremely rare, but deficits in nerve function and facial paralysis are common, and patients with such paralysis are much less likely to recover than those with Bell palsy.

Treatment is aimed at shortening the duration of the outbreak and controlling symptoms. Acyclovir and steroids are often used, but no clear prospective studies have been undertaken. In light of the known safety and effectiveness of anti–varicella-zoster or anti–herpes simplex drugs, acyclovir (800 mg five times per day) or famciclovir (500 mg three times per day) should be strongly considered, along with added prednisone.17 Aggressive analgesia is frequently needed for pain control. Vestibular symptoms can be treated with meclizine or diphenhydramine. Cranial nerve VII palsies can occur and lead to an inability to close the eye, which can cause drying and abrasions. Use of a moisturizer or lubricant ophthalmic ointment (Lacri-Lube) or other measures to moisten and protect the eye are often needed.

Trauma

External ear trauma can be classified into contusions and ecchymoses; seromas and hematomas; and lacerations, tears, and avulsions. Fluid collections and anatomic disruptions require directed attention because of the propensity for necrosis or disfigurement if managed inappropriately.

Blunt trauma can cause blood to collect in the fascial plane between the cartilage and the perichondrium. The cartilage is an avascular structure that derives its nutritional support from the blood supply of the perichondrium, and separation of the two starves the cartilage. Furthermore, neocartilage formation in the fluid collection space leads to scarring and deformation (cauliflower ear). Fluid collections can be drained by either needle aspiration or open evacuation. For cosmetic purposes, collections that form lateral (external) to the cartilage layer can be drained through a medial approach. A gentle compression dressing can then be applied by packing the ear canal with dry cotton and packing the rest of the auricle with a conforming material (gauze or foam). A gauze roll and an elastic bandage can then be carefully wrapped around the head to compress the entire bandage in place while avoiding overly tight placement, which could cause ear necrosis. Follow-up within 24 hours is needed to check for reaccumulation of fluid, which would need to be redrained.

Lacerations and avulsions need special repair techniques because of the cosmetic importance of ears. As with all facial wound repairs, minimal débridement (to minimize tissue loss) and alignment of visually eye-catching anatomic lines are key to aesthetic repair. Through-and-through lacerations of the pinna necessitate alignment and repair of the underlying cartilage. The use of deep sutures should be minimized (usually one or two), and small absorbable sutures should generally be used. The overlying skin can then be closed to realign the pinna rim first, followed by closure of the remainder of the defect. Similar technique should be used for earlobe clefts, which commonly occur after abrupt traction on earrings causes either a partial or complete tear of the earlobe. Compression packing should be applied to prevent reaccumulation of fluid. Complex disruptions with significant tissue loss can be managed conservatively, with referral for plastic or reconstructive repair at a later date to maximize the chance for a good cosmetic outcome.

Foreign Body

Direct visualization of any foreign body in an ear is critical to identification of the object and aids in the choice of removal method. A small amount of lidocaine or mineral oil instilled into the ear anesthetizes or immobilizes most insects in the ear canal within about a minute.

Methods of foreign body removal are as follows:

If removal of a foreign body from the ear canal is difficult or impossible, in most cases the patient can be treated with pain and anxiety medications and followed up in an otolaryngologic clinic in 12 to 24 hours. Exceptions to this statement are lodged button batteries (risk for caustic damage from leakage) and signs of advanced infection (redness, fever, uncontrollable pain); such cases require otolaryngologic consultation in the ED.

Cerumen, or earwax, is a naturally occurring substance that cleans, protects, and lubricates the external auditory canal. Excessive accumulation of cerumen is one of the most common reasons that patients seek medical care for ear-related reasons. When associated with symptoms, it is recommended that clinicians use ceruminolytic agents (triethanolamine, docusate sodium, saline), irrigation, or manual removal to treat a patient with impacted cerumen.18

Sudden Hearing Loss

Anatomically and physiologically, the hearing process consists of two parts. Conduction refers to the mechanical transmission of sound waves from the external environment through the outer and middle ear to the round window. The sensorineural component refers to transduction of sound waves to electrical (neural) impulses and delivery of these impulses to the brain, where they can be interpreted as sound. Hearing can be impaired by dysfunction in either or both of these pathways. The first step in evaluating hearing complaints (and the primary guide to treatment) is to ascertain the location and extent of the hearing loss. The history and physical examination provide nearly all the information needed to guide ED treatment of hearing loss. The history must include details about the timing of hearing loss, laterality, previous episodes, associated symptoms (tinnitus, vertigo, or pain), preceding events (diving, plane rides, trauma), potential placement of a foreign body, environmental noise exposure, and potential ototoxic drugs.

Tuning fork tests provide the best clues to distinguish between conductive and sensorineural hearing loss. The key component of the test is to compare how well the ear hears conduction through bone versus conduction through air. A 512-Hz fork should be used. The Weber test compares the two ears with each other (Fig. 27.4). A vibrating fork is placed midline on the top of the head or between the front top teeth (some patients find this intolerable). The patient is asked which ear hears the vibrations better. Because outside sounds (from air conduction) suppress the perception of vibratory conduction, an ear with a conductive hearing defect will “hear” the fork vibrating through bone “louder” than the other ear will. So if the fork is heard louder in one ear, either that ear has a conductive deficit or the other ear has a neural deficit (Table 27.2).

The Rinne test evaluates each ear independently (see Fig. 27.4). Normally, air conduction is more sensitive than bone conduction, and one should be able to hear a vibrating fork longer through the air than through bone. The handle of a vibrating fork is placed on the mastoid process of the side being evaluated. The vibrating end is then held near the ear canal. Normally functioning ears hear the air conduction louder and longer than the bone conduction. Perception of sound better through bone conduction indicates a conductive deficit. Lack of hearing either bone or air conduction points to sensorineural hearing loss (see Table 27.2).

Treatment

Treatment options for hearing loss are limited in the ED environment and are governed by the physical findings (Table 27.3).

Perforation of the tympanic membrane causes conductive hearing deficits, with losses being greater in the low-frequency range. Traumatic perforations usually occur in the pars flaccida (the portion inferior to the malleolar fold). Perforations generally heal spontaneously but require urgent referral to an otolaryngologist for follow-up. Larger perforations are more likely to require specialist interventions such as patching. All patients with perforations need clear counseling about the importance of keeping the affected ear clean and dry.

Fluid collections in the middle ear dampen the vibrations of the ossicles and decrease the transmission of sound waves, thereby resulting in a relative conductive hearing deficit. Acute middle ear fluid collections may respond to decongestants alone. If evidence of infection (otitis media) is present, antibiotics may be added to the treatment regimen. Solid masses may be seen behind the tympanic membrane but are not usually treatable in the ED. All patients with chronic fluid collections and masses require referral to an otolaryngologist because studies have indicated a connection between increased duration of middle ear disease and extent of sensorineural hearing loss.19,20

Sensorineural hearing loss may stem from several causes, but there are few emergency treatment options. The patient can be counseled about the variable recovery rate, and some prognosis may be given on the basis of the suspected cause of the lesion. Viral causes and inflammatory or autoimmune causes may respond to steroid treatment started in the first few days. Steroids have been regarded as standard therapy for sensorineural hearing loss suspected to be of viral etiology, although no controlled trials have shown significant benefit.21,22 Steroids should be prescribed with caution, and care must be taken to rule out infections, which may worsen with steroid treatment. Steroids should be given only if prompt follow-up is ensured. Antiviral agents (acyclovir, famciclovir, valacyclovir) are also commonly prescribed because of the possible role of herpes simplex virus type 1 as an etiologic agent in sensorineural hearing loss. No clear evidence has, however, shown a better outcome with steroids plus antiviral agents than with steroids alone.2325

Patients with suspected perilymph fistulas need absolute bed rest with head elevation to avoid raising intracranial pressure (and increasing flow of cerebrospinal fluid through the fistula). Some patients may require admission and sedation for this goal to be achieved.

Other causes of sensorineural hearing loss are not likely to be identified in the ED. These cases need expedited follow-up with an otolaryngologist for MRI and audiometry. Many patients receive relief from reassurance that their hearing loss is not a life-threatening event, but the emergency practitioner should be cautious and not give an overly optimistic picture because hearing often does not return after this type of hearing loss.

References

1 Ho T, Vrabec J. Otomycosis: clinical features and treatment implications. Otolaryngol Head Neck Surg. 2006;135:787–791.

2 Rosenfeld RM, Brown L, Cannon CR, et al. Clinical practice guideline: acute otitis externa. Otolaryngol Head Neck Surg. 2006;134:S4–23.

3 Van Balen FA, Smith WM, Zuithoff NP, et al. Clinical efficacy of three common treatments in acute otitis externa in primary care: randomized controlled trial. BMJ. 2003;327:1201–1205.

4 Rovers MM, Schilder AG, Zielhuis GA, et al. Otitis media. Lancet. 2004;363:465–473.

5 Daly KA, Giebink GS. Clinical epidemiology of otitis media. Pediatr Infect Dis J. 2000;19:S31–S36.

6 Klein JO. Microbiology. Bluestone CD, Klein JO. Otitis media in infants and children, 3rd ed, Philadelphia: Saunders, 2001.

7 Hausdorff WP, Yothers G, Dagan R, et al. Multinational study of pneumococcal serotypes causing acute otitis media in children. Pediatr Infect Dis J. 2002;21:1008–1016.

8 American Academy of Pediatrics Subcommittee on Management of Acute Otitis Media. Diagnosis and management of acute otitis media. Pediatrics. 2004;113:1451–1465.

9 Ehrlich GD, Veeh R, Wang X, et al. Mucosal biofilm formation on middle-ear mucosa in the chinchilla model of otitis media. JAMA. 2002;287:1710–1715.

10 McCormick DP, Chonmaitree T, Pittman C, et al. Nonsevere acute otitis media: a clinical trial comparing outcomes of watchful waiting versus immediate antibiotic treatment. Pediatrics. 2005;115:1455–1465.

11 Johnson NC, Holger JS. Pediatric acute otitis media: the case for delayed antibiotic treatment. J Emerg Med. 2007;32:279–284.

12 Cates C. An evidence based approach to reducing antibiotic use in children with acute otitis media: controlled before and after study. BMJ. 1999;318:715–716.

13 Siegel RM, Kiely M, Bien JP, et al. Treatment of otitis media with observation and a safety-net antibiotic prescription. Pediatrics. 2003;112:527–531.

14 Rubin Grandis J, Branstetter BF, 4th., Yu VL. The changing face of malignant (necrotizing) external otitis: clinical, radiological and anatomic correlations. Lancet Infect Dis. 2004;4:34–39.

15 Carfrae M, Kesser B. Malignant otitis externa. Otolaryngol Clin North Am. 2008;41:537–549.

16 Sweeney CJ, Gilden DH. Ramsay Hunt syndrome. J Neurol Neurosurg Psychiatry. 2001;71:149–154.

17 Murakami S, Hato N, Horiuchi J, et al. Treatment of Ramsay Hunt syndrome with acyclovir-prednisone: significance of early diagnosis and treatment. Ann Neurol. 1997;41:353–357.

18 Roland PS, Smith TL, Schwartz SE, et al. Clinical practice guidelines: cerumen impaction. Otolaryngol Head Neck Surg. 2008;139(3 Suppl 2):S1–21.

19 Mehta RP, Rosowski JJ, Voss SE, et al. Determinants of hearing loss in perforations of the tympanic membrane. Otol Neurotol. 2006;27:136–143.

20 Radaelli de Zinis LO, Campovecchi C, Parrinello G, et al. Predisposing factors for inner ear hearing loss associated with chronic otitis media. Int J Audiol. 2005;44:593–598.

21 Wei BP, Mubiru S, O’Leary S. Steroids for idiopathic sudden sensorineural hearing loss. Cochrane Database Syst Rev. 1, 2006. CD003998

22 Slattery WH, Fisher LM, Iqbal Z, et al. Oral steroid regimens for idiopathic sudden sensorineural hearing loss. Otolaryngol Head Neck Surg. 2005;132:5–10.

23 Stokroos RJ, Albers FW, Tenvergert EM. Antiviral treatment of idiopathic sudden sensorineural hearing loss: a prospective randomized double-blind clinical trial. Acta Otolaryngol. 1998;118:488–495.

24 Uri N, Doweck I, Cohen-Kerem R, et al. Acyclovir in the treatment of idiopathic sudden sensorineural hearing loss. Otolaryngol Head Neck Surg. 2003;128:544–549.

25 Tucci DL, Farmer JC, Jr., Kitch RD, et al. Treatment of sudden sensorineural hearing loss with systemic steroids and valacyclovir. Otol Neurotol. 2002;23:301–308.